Cargando…
A critical appraisal of MAO-B inhibitors in the treatment of Parkinson’s disease
Since the 1980s, the MAO-B inhibitors have gained considerable status in the therapy of the Parkinson’s disease. In addition to the symptomatic effect in mono- and combination therapies, a neuroprotective effect has repeatedly been a matter of some discussion, which has unfortunately led to a good m...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Vienna
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188534/ https://www.ncbi.nlm.nih.gov/pubmed/35107654 http://dx.doi.org/10.1007/s00702-022-02465-w |